Structured Obligations Corp announces distribution for 2026
Structured Obligations Corp Long Term Certs Series 2003-4 announces a distribution to holders of its Select Notes Trust LT 2003-4, totaling $168,696.63.
Biohaven receives FDA nod for Vyglxia resubmission review
Biohaven Ltd. announces FDA acceptance of its resubmission for Vyglxia, a drug for spinocerebellar ataxia, marking a crucial step in its development.
Structured Obligations Corp Announces Distribution to Holders
Structured Obligations Corp Select Notes Trust LT Series 2003-1 announces a distribution to certificate holders, reflecting ongoing activity in asset-backed securities.
MBX Biosciences appoints Peter Radovich as new director
MBX Biosciences has appointed Peter Radovich to its board of directors, signaling a strategic move in the pharmaceutical preparations sector.
Fractyl Health announces workforce reduction, leadership change
Fractyl Health, Inc. announces a 45% workforce reduction and the retirement of its President, Jay Caplan, as part of a strategic shift.
MIRA Pharmaceuticals Reports Positive Results for MIRA-55
MIRA Pharmaceuticals announces promising results from a preclinical study of MIRA-55, a potential pain relief drug, aiming for an IND submission in 2027.
Kearny Financial holds Annual Meeting; key votes reported
Kearny Financial Corp. reports results from its Annual Meeting, including director elections and auditor appointments, impacting shareholder engagement.
Plumas Bancorp unveils new investor presentation
Plumas Bancorp has announced a new investor presentation, highlighting its commitment to transparency and engagement with stakeholders.
Nevada Canyon Gold Corp. updates on Lapon Canyon Project
Nevada Canyon Gold Corp. shares insights on the Lapon Canyon Project following recent drill results, impacting the gold and silver ores sector.
Aptera Motors extends Interim CFO Tom DaPolito's contract
Aptera Motors Corp has extended the contract of Interim CFO Tom DaPolito through 2027, signaling a commitment to stable financial leadership.
Tempest Therapeutics holds special meeting, adjourns for vote
Tempest Therapeutics' special meeting to amend voting requirements adjourns without approval, with a follow-up meeting scheduled for November 12, 2026.
Worthington Steel Issues Statement Ahead of Kloeckner EGM
Worthington Steel addresses Kloeckner & Co's upcoming extraordinary general meeting, detailing the potential impact of a key vote.
Roivant Sciences reports positive Phase 3 results for brepocitinib
Roivant Sciences announces positive Phase 3 results for brepocitinib, a potential treatment for non-infectious uveitis, signaling a breakthrough in the pharmaceutical industry.
Genprex highlights TUSC2 gene findings in new research release
Genprex, Inc. reveals new research on TUSC2 gene's role in brain aging, potentially impacting cancer therapies and neurodegenerative disease understanding.
U.S. Government Invests $250 Million in Nova Minerals Project
Nova Minerals Corp secures $250 million from the U.S. government to support its critical minerals processing hub in Alaska, enhancing its operational capabilities.
Labcorp Declares $0.72 Quarterly Dividend for Shareholders
Labcorp Holdings Inc. announces a quarterly cash dividend of $0.72 per share, payable on December 11, 2026, reflecting its strong performance in medical laboratories.
Amalgamated Financial Corp. Declares Quarterly Dividend
Amalgamated Financial Corp. announces a quarterly dividend of $0.17 per share, payable on November 19, 2026, reflecting its commitment to shareholder returns.
Old Second Bancorp declares cash dividend of $0.08 per share
Old Second Bancorp Inc. announces a cash dividend of $0.08 per share, reflecting financial stability and enhancing shareholder value.
Oncolytics Biotech reveals REO 033 trial details for ESMO 2026
Oncolytics Biotech announces REO 033 trial details to be presented at ESMO 2026, showcasing potential advancements in colorectal cancer treatment.
Microbot Medical sets annual meeting, announces patent wins
Microbot Medical Inc. announces its annual meeting date and new patent approvals, signaling growth in the surgical instruments sector.